Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 40Endocrine 40Gastrointestinal 4CNS 4Sarcoma 1Dermatologic 1

Conditions

Carcinoma, Merkel Cell 2Neuroendocrine Tumors 1Carcinoma 1

Interventions

fludarabine phosphate 2avelumab 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2Cyclophosphamide 2veliparib 1romidepsin 1pasireotide 1lutetium Lu 177 dotatate 1fludarabine 1entrectinib 1alectinib 1Temozolomide 1Specimen Handling 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Lutetium-177 1Lactones 1Interleukin-13 1Immunotherapy 1FAPI-46 1Drug Therapy 1Depsipeptides 1Capecitabine 1Cabergoline 1Biopsy 1Biological Therapy 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroendocrine Tumors × lutetium Lu 177 dotatate × Dermatologic × Clear all
NCT04261855 2026-03-27

GoTHAM

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Active not recruiting
19 enrolled
DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡